Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Healthequity Inc (NASDAQ: HQY) closed the day trading at $84.56 down -10.19% from the previous closing price of $94.15. In other words, the price has decreased by -$10.19 from its previous closing price. On the day, 2.3 million shares were traded. HQY stock price reached its highest trading level at $91.335 during the session, while it also had its lowest trading level at $84.44.
Ratios:
For a better understanding of HQY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 23.36 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.49. For the most recent quarter (mrq), Quick Ratio is recorded 4.13 and its Current Ratio is at 4.13. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.
On December 09, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $118.
On November 13, 2025, BMO Capital Markets started tracking the stock assigning a Market Perform rating and target price of $100.BMO Capital Markets initiated its Market Perform rating on November 13, 2025, with a $100 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 19 ’25 when Ladd Delano sold 1,500 shares for $94.72 per share. The transaction valued at 142,080 led to the insider holds 73,979 shares of the business.
Rosner Elimelech sold 10,959 shares of HQY for $1,046,090 on Dec 18 ’25. The EVP, CHIEF TECHNOLOGY OFFICER now owns 45,742 shares after completing the transaction at $95.45 per share. On Dec 19 ’25, another insider, DELANO LADD, who serves as the Officer of the company, bought 4,500 shares for $95.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HQY now has a Market Capitalization of 7312355328 and an Enterprise Value of 7943497216. As of this moment, Healthequity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 38.75, and their Forward P/E ratio for the next fiscal year is 18.50. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.93. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.60 while its Price-to-Book (P/B) ratio in mrq is 3.39. Its current Enterprise Value per Revenue stands at 6.155 whereas that against EBITDA is 17.475.
Stock Price History:
The Beta on a monthly basis for HQY is 0.24, which has changed by -0.091303945 over the last 52 weeks, in comparison to a change of 0.19226205 over the same period for the S&P500. Over the past 52 weeks, HQY has reached a high of $116.65, while it has fallen to a 52-week low of $74.07. The 50-Day Moving Average of the stock is -12.57%, while the 200-Day Moving Average is calculated to be -10.74%.
Shares Statistics:
Over the past 3-months, HQY traded about 843.85K shares per day on average, while over the past 10 days, HQY traded about 770700 shares per day. A total of 85.61M shares are outstanding, with a floating share count of 83.52M. Insiders hold about 2.25% of the company’s shares, while institutions hold 106.09% stake in the company. Shares short for HQY as of 1767139200 were 4411284 with a Short Ratio of 5.23, compared to 1764288000 on 4351292. Therefore, it implies a Short% of Shares Outstanding of 4411284 and a Short% of Float of 5.9899997.
Earnings Estimates
The market rating for Healthequity Inc (HQY) is a result of the insights provided by 15.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $1.14, with high estimates of $1.28 and low estimates of $1.02.
Analysts are recommending an EPS of between $4.01 and $3.92 for the fiscal current year, implying an average EPS of $3.95. EPS for the following year is $4.57, with 14.0 analysts recommending between $5.05 and $4.34.
Revenue Estimates
15 analysts predict $332.48M in revenue. The current quarter. It ranges from a high estimate of $339.21M to a low estimate of $327.89M. As of. The current estimate, Healthequity Inc’s year-ago sales were $311.82MFor the next quarter, 15 analysts are estimating revenue of $350.91M. There is a high estimate of $356.86M for the next quarter, whereas the lowest estimate is $345.1M.
A total of 15 analysts have provided revenue estimates for HQY’s current fiscal year. The highest revenue estimate was $1.32B, while the lowest revenue estimate was $1.31B, resulting in an average revenue estimate of $1.31B. In the same quarter a year ago, actual revenue was $1.2BBased on 14 analysts’ estimates, the company’s revenue will be $1.41B in the next fiscal year. The high estimate is $1.43B and the low estimate is $1.39B.
